Insulin infusion treatment system based on Zigbee technology

Abstract

The invention provides an insulin infusion treatment system based on a Zigbee technology, comprising a management terminal and a client terminal, wherein data are transmitted between the management terminal and the client terminal through Zigbee. The management terminal comprises an insulin infusion treatment managing system and a Zigbee network coordinator connected with the insulin infusion treatment managing system, and the client terminal comprises an electronic control unit and a Zigbee wireless module connected with the electronic control unit, wherein the Zigbee wireless module and the Zigbee network coordinator form a Zigbee wireless network. The management terminal receives data from the client terminal through Zigbee wireless connection, then the data are treated through the insulin infusion treatment managing system, and the treated data are sent to the electronic unit of the client terminal through the Zigbee wireless network to control the work of the client terminal. According to the insulin infusion treatment system, the whole setting process of an insulin pump is greatly simplified, and a set interface is concise and clear, is easy to operate and is flexible to amend, in addition, the treatment effect and treatment efficiency are greatly improved, therefore, the medical treatment cost is greatly reduced.

Description

Technical field [0001] The invention relates to a medical instrument, and in particular to an insulin infusion treatment system based on Zigbee technology. Background technique [0002] Diabetes is an endocrine-metabolic disease characterized by high blood sugar. It is characterized by the absolute or relative lack of insulin secretion by the pancreas and the reduced sensitivity of target cells to insulin, causing metabolic disorders of carbohydrates, proteins, fats, electrolytes and water. Mainly divided into type I and type II diabetes. Type I diabetes is also called insulin-dependent diabetes, which can only be treated with insulin, because the insulin secreting cells of the pancreas in patients with type I diabetes have been completely destroyed and lost the function of secreting insulin. Type 2 diabetes is also called non-insulin-dependent diabetes. The ability of patients to produce insulin is not completely lost. Some patients even produce too much insulin in their bodie...

AI Technical Summary

Problems solved by technology

[0005] In order to be portable, the insulin injection pump is small in size, so the size of the membrane buttons installed on it is smaller, and all the setting operations of the pump are set through several buttons and LCD hierarchical menus. The setting procedure is cumbersome and professional. Strong, setting work is an extremely complicated task for doctors. Once the patient’s diet and life patterns change, parameters such as insulin basal rate and pre-meal dose must be readjusted. The complexity of the insulin pump setting process makes doctors work more efficiently. Low, high technical requirements, resulting in a great waste of medical resources

These shortcomings have greatly restricted the use and promotion of insulin pumps, and at the same time made the cost of insulin pump treatment high. Generally, a diabetic patient will spend more than 10,000 yuan for intensive hospitalization for a week or so. The high medical expenses make ordinary diabetic patients Unbearable

[0006] To sum up, the disadvantages of cumbersome setting and troublesome adjustment when using a single insulin pump at present make doctors' work efficiency low and technical requirements high, resulting in a great waste of medical resources, which is not conducive to reducing treatment costs and increasing patients' medical care. burden

Images